共 173 条
[1]
Cunningham D(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20
[2]
Allum WH(2015)Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for esophageal or junctional cancer (CROSS): long-term results of a randomized controlled trial Lancet Oncol 16 1090-1098
[3]
Stenning SP(1994)Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 2680-2686
[4]
Thompson JN(2014)Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials J Clin Oncol 32 385-391
[5]
Van de Velde CJH(2020)Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial Ann Oncol 31 236-245
[6]
Nicolson M(2022)The use of miRNAs in predicting response to neoadjuvant therapy in oesophageal cancer Cancers (Basel) 14 1171-1604
[7]
Scarffe JH(2010)Clinical practice. N Engl J Med 362 1597-123
[8]
Lofts FJ(2012) infection Science 338 120-86
[9]
Falk SJ(2015)Intestinal inflammation targets cancer-inducing activity of the microbiota Science 348 80-812
[10]
Iveson TJ(2013)Cancer and the microbiota Nat Rev Cancer 13 800-5581